The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – A post-hoc analysis of a Phase 3, single-arm, open-label trial

Title
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – A post-hoc analysis of a Phase 3, single-arm, open-label trial
Authors
Keywords
Homozygous familial hypercholesterolaemia, Lomitapide, Lipoprotein apheresis
Journal
ATHEROSCLEROSIS
Volume 240, Issue 2, Pages 408-414
Publisher
Elsevier BV
Online
2015-03-15
DOI
10.1016/j.atherosclerosis.2015.03.014

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started